Skip to main content

Table 2 Correlates of mortality among children who initiated HAART.

From: Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort

Univariate

     

Characteristic

HR

(95% CI)

p

Number

Percentage

(out of 149)

Clinical, sociodemographic

     

Age ≥3 yrs)

1.30

(0.47-3.62)

0.6

147

99

Sex (female)

0.79

0.33 - 1.91

0.6

149

100

WHO stage 4

3.08

1.17-8.13

0.02

145

97

Hospitalized since birth

7.09

0.95-53.14

0.06

147

97

Weight-for-height z score < -2

3.41

1.28-9.08

0.01

142

95

Tuberculosis at baseline

1.49

0.62-3.57

0.4

149

100

Lost parent

1.25

0.50-3.13

0.6

149

100

Laboratory

     

Log HIV-1 RNA

0.80

0.58-1.11

0.2

127

85

CD4 count (per 100 cells)

0.86

0.73-1.02

0.09

145

97

CD4 percent < 15%

1.74

0.40-7.56

0.5

137

92

Hemoglobin (< 9 g/dl)

3.00

1.21-7.39

0.02

146

98

Total lymphocyte count (per 1000)

0.79

0.63 - 1.00

0.05

144

97

Serum albumin

0.93

0.86-1.00

0.05

137

92

Multivariate

     

Weight-for-height z-score < -2

2.48

0.87-7.04

0.09

142

95

Hemoglobin (<9 g/dl)

2.95

1.04-8.35

0.04

146

98

WHO stage 4

3.03

0.96-9.55

0.06

147

99